Condition: Basal Cell Carcinoma · Squamous Cell Carcinoma Skin · Non-melanoma Skin Cancer · Sponsor: Kantonsspital Winterthur KSW
The SAHARA trial assesses wether combining ultrahypofractionated accelerated radiotherapy (RT) with hyperthermia is as effective as standard hypofractionated high-dose radiation in treating non-melanoma skin cancer (NMSC).
This description comes directly from the study's public registry record.
Nidar Batifi, MSc · +41522665361 · sahara-team@ksw.ch
Daniel Zwahlen, Prof. Dr. med. · +4152 266 26 53 · radioonkologie@ksw.ch
Always discuss trial participation with your own doctor first.
| Kantonsspital Aarau | Aarau, Canton of Aargau, Switzerland | Recruiting |
| Kantonsspital Winterthur | Winterthur, Canton of Zurich, Switzerland | Recruiting |
| Lindenhofgruppe | Bern, Switzerland | Recruiting |
| Luzerner Kantonsspital | Lucerne, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06384053